AQA Stock Overview
Develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 5/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Advanced Medical Solutions Group plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£2.48 |
| 52 Week High | UK£3.02 |
| 52 Week Low | UK£2.06 |
| Beta | 0.69 |
| 1 Month Change | -7.46% |
| 3 Month Change | 5.98% |
| 1 Year Change | 15.89% |
| 3 Year Change | -29.14% |
| 5 Year Change | 2.06% |
| Change since IPO | 1,932.79% |
Recent News & Updates
Recent updates
Shareholder Returns
| AQA | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 1.6% | 3.9% | 4.1% |
| 1Y | 15.9% | -9.7% | 17.2% |
Return vs Industry: AQA exceeded the German Medical Equipment industry which returned -9.6% over the past year.
Return vs Market: AQA matched the German Market which returned 16.4% over the past year.
Price Volatility
| AQA volatility | |
|---|---|
| AQA Average Weekly Movement | 6.8% |
| Medical Equipment Industry Average Movement | 5.4% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in DE Market | 12.1% |
| 10% least volatile stocks in DE Market | 2.8% |
Stable Share Price: AQA has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: AQA's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 1,500 | Chris Meredith | www.admedsol.com |
Advanced Medical Solutions Group plc, together with its subsidiaries, develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. It operates in two segments, Surgical and Woundcare. The company offers surgical products, such as tissue adhesives, sutures, haemostats, internal fixation devices, and internal sealants under LiquiBand, RESORBA, LiquiBandFix8, LIQUIFIX, and Seal-G brand names.
Advanced Medical Solutions Group plc Fundamentals Summary
| AQA fundamental statistics | |
|---|---|
| Market cap | €551.36m |
| Earnings (TTM) | €13.23m |
| Revenue (TTM) | €155.77m |
41.7x
P/E Ratio3.5x
P/S RatioIs AQA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AQA income statement (TTM) | |
|---|---|
| Revenue | UK£131.11m |
| Cost of Revenue | UK£59.73m |
| Gross Profit | UK£71.38m |
| Other Expenses | UK£60.25m |
| Earnings | UK£11.13m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Mar 19, 2025
| Earnings per share (EPS) | 0.051 |
| Gross Margin | 54.45% |
| Net Profit Margin | 8.49% |
| Debt/Equity Ratio | 32.7% |
How did AQA perform over the long term?
See historical performance and comparisonDividends
1.1%
Current Dividend Yield47%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/03/18 12:30 |
| End of Day Share Price | 2025/03/18 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Advanced Medical Solutions Group plc is covered by 22 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Samuel England | Berenberg |
| Julie Simmonds | Canaccord Genuity |
| Keith Redpath | Cavendish |